Other Income & Expense

Impairment on Equity Investment

Medtronic Impairment on Equity Investment decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther Income & Expense
First reportedQ3 2024
Last reportedQ3 2026Feb 24, 2026
Metric ID: tjx_impairment_on_equity_investment

Historical Data

3 periods
 Q3 '24Q3 '25Q3 '26
Value$0.00$71.00M$0.00
QoQ Change——-100.0%
YoY Change——-100.0%
Range$0.00 – $71.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Medtronic's impairment on equity investment?
Medtronic (MDT) reported impairment on equity investment of $0.00 in Q4 2025.